Skip to main content
Clinical Trials/NCT01575145
NCT01575145
Completed
Phase 4

Helping Hospitalized Patients Quit Smoking

Mayo Clinic1 site in 1 country600 target enrollmentMay 2012

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Tobacco Abuse Cigarette
Sponsor
Mayo Clinic
Enrollment
600
Locations
1
Primary Endpoint
7-day point prevalence tobacco abstinence at 6 months after hospitalization
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The study is being done to determine whether an in-hospital intervention using a brief intervention to facilitate quitline utilization will increase quitline utilization by hospitalized smokers, and will increase post hospital discharge smoking abstinence rates.

Study participants will be randomized to receive either a brief quitline facilitation intervention , or a control intervention of a brief stop-smoking message.

The study will also compare healthcare costs and utilization in the first six months following hospitalization between the two groups.

Registry
clinicaltrials.gov
Start Date
May 2012
End Date
November 2015
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

David Warner

Associate Director of Clinical and Translational Research

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

  • Current smoker, Resident of Olmsted County, Inpatient admission to St. Marys or Rochester Methodist Hospital, Able to participate fully in all study aspects, Available for follow-up

Exclusion Criteria

  • Current active treatment for tobacco use initiated prior to hospitalization

Outcomes

Primary Outcomes

7-day point prevalence tobacco abstinence at 6 months after hospitalization

Time Frame: 6 months after hospitalization

Secondary Outcomes

  • Self-efficacy(Immediately after the delivery of the brief intervention (day of enrollment))

Study Sites (1)

Loading locations...

Similar Trials